More than 50 years of research on breastmilk nutrition

Human milk research

Human milk is more than nutrition. It is a dynamic, living system that evolves to meet the needs of each infant. Rich in essential nutrients and bioactive components, it supports not only growth and development, but also immunity, digestion, and long-term health.

 

At Danone Research and Innovation , we have dedicated over 50 years to exploring the complexity of human milk, as well as understanding and supporting breastfeeding, with the goal of transforming this knowledge into safe, effective nutritional solutions that support all infants, especially those who cannot be breastfed.

Human milk: the gold standard for early life nutrition

Human milk is uniquely suited to meet the needs of infants. Its composition naturally adapts to support healthy growth and development during the first months of life. For this reason, the World Health Organization (WHO) recommends exclusive breastfeeding for the first six months, followed by continued breastfeeding alongside appropriate complementary foods up to two years and beyond.

A wide range of benefits for infants

Breast milk provides both immediate and long-lasting health advantages. Its complex makeup offers:

  • Protection against infections and illnesses by supplying antibodies and immune-supporting compounds1.
  • Reduced risk of allergies and asthma, thanks to its role in shaping the infant’s immune system2.
  • Support for optimal physical growth and organ development during this critical window3.

  • Enhanced brain and visual development, due to its content in long-chain fatty acids and other essential nutrients4.

Health advantages for mothers

Breastfeeding also offers important benefits to maternal health:

  • In the short term, it may support postpartum recovery, help regulate body weight5, and contribute to emotional well-being6.

  • In the long term, it is associated with a lower risk of certain cancers7, such as breast and ovarian, as well as reduced chances of developing conditions like type 2 diabetes8 and cardiovascular disease9.

More than nutrition: strong emotional and physiological effects

The first 1,000 days of life, from conception to age of two, are foundational for long-term health. Breastfeeding supports this critical period not only nutritionally, but also by fostering a deep emotional connection between mother and child. This bond can positively influence the emotional and psychological development of both.

On a physiological level, human milk helps shape the infant’s immune system10, supports the development of a healthy gut11 , and may even influence taste preferences in later childhood12. These effects underscore the profound and lasting influence of breastfeeding on health and well-being.

Human milk as a source of innovation

Breast milk remains a source of continuous inspiration for Danone's nutritional research. Rather than trying to replicate it entirely, we focus on translating its most impactful benefits into nutritional innovations.

This includes:

  • Developing formulas enriched with human milk oligosaccharides (HMOs) to promote gut health and immunity.

  • Designing lipids that mimic the functionalities of milk fats.

  • Using proteins and peptides for their protective effects.

Unlocking the secrets of milk lipids

Lipids constitute nearly 50% of human milk’s energy content, but their role extends far beyond caloric supply.

These molecules are critical for brain development, where long-chain polyunsaturated fatty acids (LCPUFAs) like DHA and arachidonic acid integrate into neuronal membranes, supporting cerebral plasticity13.

Moreover, complex lipids such as phospholipids, gangliosides, and sphingolipids, abundant in the milk fat globule membrane (MFGM) act as structural components of brain tissue and modulate cell signaling pathways essential for neurodevelopment13.

50%
of human milk’s energy content is provided by lipids

Human milk’s lipid architecture also plays a pivotal role in immune modulation and intestinal health. The MFGM, a trilayered structure surrounding fat globules, contains bioactive compounds that resist digestive enzymes, delivering immune-protective effects against pathogens14. Additionally, MFGM lipids and their metabolites regulate gut microbiota composition, strengthen intestinal barrier function, and reduce inflammation, lowering risks of conditions like necrotizing enterocolitis in preterm infants14.

A key distinction lies in the structural organization of lipids. Human milk’s large fat globules with MFGM differ starkly from standard infant formulas, which generally use smaller, protein-stabilized lipid droplets lacking this bioactive membrane15. This structural difference impacts bioavailability: MFGM lipids are digested more slowly, ensuring sustained nutrient release and efficient absorption of fat-soluble vitamins and LCPUFAs. Emerging research aims to replicate this architecture in formulas, with studies showing that MFGM-enriched formulations improve cognitive outcomes and immune responses in infants, bridging gaps between breastfed and formula-fed groups15.

This is why Danone's innovations in infant nutrition now focus on mimicking human milk’s lipid profile and structure

Mimicking digestion: improving bioavailability

Understanding how infants digest and absorb nutrients is central to developing effective nutritional products.

To optimize our formulas, we employ advanced in vitro digestion models that simulate the infant gastrointestinal tract, enabling precise study of nutrient bioavailability. Key findings highlight the importance of lipid droplet structure:

  • Phospholipid-coated lipid droplets, designed to mimic human milk’s natural fat globules, slow gastric lipid emptying and modulate lipolysis. This structural similarity ensures a digestion trajectory closer to breast milk, enhancing lipid utilization and metabolic efficiency16.

  • Compared to conventional formulas (small, protein-coated droplets), these larger droplets delay gastric lipolysis but accelerate intestinal-phase digestion, promoting efficient fatty acid absorption and oxidation over storage, a pattern linked to healthier growth and neurodevelopment16.

  • Clinical trials demonstrate that such innovations reduce the omega-6 to omega-3 ratio in blood, improving omega-3 availability for brain development, and yield growth metrics and metabolic outcomes closer to breastfed infants17.

By replicating human milk’s lipid architecture, our formulations narrow functional gaps between formula and breast milk, ensuring nutrients are delivered in bioavailable forms that support infant health.

50 years of discoveries in human milk research

Behind Danone's research is a dedicated team of experts in pediatrics, microbiology, immunology, nutrition, and systems biology. Spread across multiple research centers worldwide, they work closely with universities, hospitals, and other partners to conduct rigorous studies on human milk.

Since the 1970s, our teams have contributed to significant advancements in the field, including the identification and characterization of HMOs, the study of immune-active proteins, and the analysis of lipid complexity.

This legacy of research has not only shaped our own product development, but also contributed to the broader scientific community. By continuously publishing in peer-reviewed journals and collaborating with leading academic institutions, we help build a shared understanding of how early life nutrition impacts lifelong health.

This long-standing commitment has led to numerous breakthroughs, including:

  • 1977: following our early effort in 1968 to adjust the casein-to-whey ratio in formulas to better reflect the protein structure of human milk, we continued to deepen our understanding of milk composition throughout the 1970s, reinforcing our leadership in protein science18.

  • 1983: we uncovered that long-chain polyunsaturated fatty acids exist in both polar and non-polar lipid forms within human milk, and that these structures play a key role in their functional properties, an insight that has guided lipid innovation ever since19.

  • 1994: we were among the first to characterize the diverse and genetically driven composition of human milk oligosaccharides (HMOs), including the identification of long-chain HMOs previously undetected20.

  • 2003: our research confirmed the presence of beneficial microorganisms such as lactobacilli and bifidobacteria in human milk, highlighting its role in establishing a healthy microbial environment for the infant21.

  • 2010: we demonstrated that the composition and concentration of HMOs evolve over the course of lactation. These variations have been shown to influence the development of the infant’s microbiota, building on our earlier classification of four major HMO families in 199722-23.

  • 2016: By applying advanced proteomic techniques, we identified around 600 previously unknown proteins in human milk—bringing the total number described to over 3,500. This significantly expanded the scientific understanding of its proteomic complexity24.

  • 2024: launch of a new infant formula containing milk droplets that closely mimic the structure found in mothers' milk

Furthering the science of human milk

Today, our commitment to human milk research continues to evolve. We use cutting-edge technologies such as multi-omics, metabolomics, and advanced bioinformatics to explore the intricate relationships between milk composition and infant health outcomes.

These tools allow us to:

  • Map the dynamic changes in milk over time.

  •  Understand how maternal diet and health influence breastmilk composition.

  • Identify new bioactive compounds with potential health benefits.

This next generation of research is not only deepening our understanding of human milk, but also shaping the future of early life nutrition, helping every child, everywhere, grow up healthy and strong.

  1. Palmeira P, Carneiro-Sampaio M. Immunology of breast milk. Rev Assoc Med Bras (1992). 2016 Sep;62(6):584-593. doi: 10.1590/1806-9282.62.06.584. PMID: 27849237.

  2. Koukou Z, Papadopoulou E, Panteris E, Papadopoulou S, Skordou A, Karamaliki M, Diamanti E. The Effect of Breastfeeding on Food Allergies in Newborns and Infants. Children (Basel). 2023 Jun 12;10(6):1046. doi: 10.3390/children10061046. PMID: 37371277; PMCID: PMC10297573.

  3. Wallenborn JT, Levine GA, Carreira Dos Santos A, Grisi S, Brentani A, Fink G. Breastfeeding, Physical Growth, and Cognitive Development. Pediatrics. 2021 May;147(5):e2020008029. doi: 10.1542/peds.2020-008029. PMID: 33888567.

  4. Isaacs EB, Fischl BR, Quinn BT, Chong WK, Gadian DG, Lucas A. Impact of breast milk on intelligence quotient, brain size, and white matter development. Pediatr Res. 2010 Apr;67(4):357-62. doi: 10.1203/PDR.0b013e3181d026da. PMID: 20035247; PMCID: PMC2939272.

  5. Stuebe, A. M., & Rich-Edwards, J. W. (2009). "The reset hypothesis: lactation and maternal metabolism." American Journal of Perinatology, 26(1), 81-88

  6. Figueiredo, B., Canário, C., & Field, T. (2014). "Breastfeeding is negatively affected by prenatal depression and reduces postpartum depression." Psychological Medicine, 44(5), 927-936

  7. Breastfeeding and maternal health outcomes: a systematic review and meta-analysis." Acta Paediatrica, 104(S467), 96-113.

  8. Gunderson, E. P., et al. (2018). "Lactation Duration and Progression to Diabetes in Women Across the Childbearing Years: The 30-Year CARDIA Study." JAMA Internal Medicine, 178(3), 328-337.

  9. Tschiderer, L., Seekircher, L., Kunutsor, S. K., Peters, S. A. E., O'Keeffe, L. M., & Willeit, P. (2022). "Breastfeeding is associated with a reduced maternal risk of cardiovascular disease: Systematic review and meta-analysis involving 1 million women." Journal of the American Heart Association, 11(2), e022746

  10. Carr LE, Virmani MD, Rosa F, Munblit D, Matazel KS, Elolimy AA, Yeruva L. Role of Human Milk Bioactives on Infants' Gut and Immune Health. Front Immunol. 2021 Feb 12;12:604080. doi: 10.3389/fimmu.2021.604080. PMID: 33643310; PMCID: PMC7909314.

  11. Wang, S., et al. (2025). Maternal Milk Orchestrates the Development of Infant Gut Microbiota. Research, 2025, 0558.

  12. Schwartz, C., et al. (2017). Early Taste Experiences and Later Food Choices. Appetite, 114, 3-9.

  13. Lidewij Schipper, Gertjan van Dijk, Eline M. van der Beek. Milk lipid composition and structure; The relevance for infant brain development. OCL 27 5 (2020). DOI: 10.1051/ocl/2020001

  14. Ramiro-Cortijo D, Singh P, Liu Y, Medina-Morales E, Yakah W, Freedman SD, Martin CR. Breast Milk Lipids and Fatty Acids in Regulating Neonatal Intestinal Development and Protecting against Intestinal Injury. Nutrients. 2020 Feb 19;12(2):534. doi: 10.3390/nu12020534. PMID: 32092925; PMCID: PMC7071444.

  15. Claire Bourlieu, Amélie Deglaire, Samira Cassia de Oliveira, Olivia Ménard, Yann Le Gouar, Frédéric Carrière and Didier Dupont BIOAVAILABILITY AND TISSUE-TARGETING DIETARY LIPIDS: NEWAPPROACHES TO THEIR FORMULATION? https://doi.org/10.1051/ocl/2017010

  16. Thomassen, E. Abrahamse, M. Mischke, M. Becker, N. Bartke, J. Knol, I.B. Renes. In vitro gastrointestinal lipid handling and bioaccessibility rate of infant formula with large phospholipid-coated lipid droplets are different from those of standard formula and closer to human milk. Food Hydrocolloids, Volume 156, 2024, 110336, ISSN 0268-005X, https://doi.org/10.1016/j.foodhyd.2024.110336.

  17. Breij LM, Abrahamse-Berkeveld M, Vandenplas Y, Jespers SNJ, de Mol AC, Khoo PC, Kalenga M, Peeters S, van Beek RHT, Norbruis OF, Schoen S, Acton D, Hokken-Koelega ACS; Mercurius Study Group. An infant formula with large, milk phospholipid-coated lipid droplets containing a mixture of dairy and vegetable lipids supports adequate growth and is well tolerated in healthy, term infants. Am J Clin Nutr. 2019 Mar 1;109(3):586-596. doi: 10.1093/ajcn/nqy322. PMID: 30793165; PMCID: PMC6408203.

  18. Wemmer U, Meb Fortschr Med. Published on 1977;95(7):441-6

  19. Harzer G, et al. Am J Clin Nutr. Published on 1983;37(4), 612-21

  20. Stahl B, et al. Anal Biochem. Published on 1994;223(2), 218-26

  21. Martin R R, et al. J Pediatr. Published on 2003;143(6), 754-58

  22. Thurl S, et al. Br J Nutr. Published on 2010;104:1261–71

  23. Coppa GV, et al. JPGN. Published on 2011

  24. Van Herwijnen MJ, et al. Mol Cell Proteomics. Published on 2016;15(11):3412-23
x